Agilon Health PE Ratio 2020-2023 | AGL
Current and historical p/e ratio for Agilon Health (AGL) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Agilon Health PE ratio as of May 14, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Agilon Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-14 | 5.50 | 0.00 | |
| 2023-12-31 | 12.55 | $-0.65 | 0.00 |
| 2023-09-30 | 17.76 | $-0.22 | 0.00 |
| 2023-06-30 | 17.34 | $-0.21 | 0.00 |
| 2023-03-31 | 23.75 | $-0.22 | 0.00 |
| 2022-12-31 | 16.14 | $-0.26 | 0.00 |
| 2022-09-30 | 23.42 | $-0.26 | 0.00 |
| 2022-06-30 | 21.83 | $-0.28 | 0.00 |
| 2022-03-31 | 25.35 | $-1.02 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.143B | $4.316B |
| agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.220B | 15.71 |
| Cencora (COR) | United States | $44.462B | 17.33 |
| ICON (ICLR) | Ireland | $25.533B | 24.10 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Avantor (AVTR) | United States | $16.499B | 24.29 |
| CochLear (CHEOY) | Australia | $14.039B | 0.00 |
| Viatris (VTRS) | United States | $13.526B | 4.04 |
| Revvity (RVTY) | United States | $13.024B | 22.85 |
| Natera (NTRA) | United States | $12.689B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.061B | 39.68 |
| Charles River Laboratories (CRL) | United States | $11.765B | 22.53 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.621B | 0.00 |
| Solventum (SOLV) | United States | $10.905B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.566B | 0.00 |
| HealthEquity (HQY) | United States | $6.637B | 49.59 |
| Organon (OGN) | United States | $5.385B | 5.11 |
| Bausch + Lomb (BLCO) | Canada | $5.192B | 20.80 |
| Doximity (DOCS) | United States | $4.289B | 31.93 |
| PACS (PACS) | United States | $3.766B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.289B | 30.09 |
| Sotera Health (SHC) | United States | $3.221B | 15.81 |
| Life Times (LTH) | United States | $2.927B | 30.67 |
| GoodRx Holdings (GDRX) | United States | $2.646B | 95.71 |
| Progyny (PGNY) | United States | $2.609B | 44.92 |
| Premier (PINC) | United States | $2.362B | 8.84 |
| AMN Healthcare Services Inc (AMN) | United States | $2.242B | 8.89 |
| Teladoc Health (TDOC) | United States | $2.111B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.935B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.926B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.546B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.323B | 0.00 |
| Embecta (EMBC) | United States | $0.818B | 5.56 |
| CareDx (CDNA) | United States | $0.780B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.718B | 7.62 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.655B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.611B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.555B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| Enhabit (EHAB) | United States | $0.433B | 43.20 |
| MultiPlan (MPLN) | United States | $0.412B | 0.00 |
| LifeMD (LFMD) | United States | $0.403B | 0.00 |
| ModivCare (MODV) | United States | $0.378B | 7.08 |
| Beauty Health (SKIN) | United States | $0.338B | 0.00 |
| DocGo (DCGO) | United States | $0.329B | 17.56 |
| Sera Prognostics (SERA) | United States | $0.295B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Sharecare (SHCR) | United States | $0.257B | 0.00 |
| Biodesix (BDSX) | United States | $0.174B | 0.00 |
| So-Young (SY) | China | $0.129B | 43.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.74 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |